Sort Results:

List of Materials

"AI Ate My Homework" summer lecture series


"AI Ate My Homework" summer lecture series by Cyclica. Artificial Intelligence, machine learning, and neural networks are all the range in drug discovery.  This playlist includes seven webinars from Cyclica’s summer series, with...

Cyclica, Inc.

Presenter: Cyclica, Inc.

Academic Drug Discovery in the Center for Integrative Chemical Biology and Drug Discovery

Learn more about the Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina Chapel Hill . This presentation discusses the Center's vision, mission, capabilities, process and portfolio and highlights.


Center for Integrative Chemical Biology and Drug Discovery

University of North Carolina Chapel Hill

Presenter: Stephen V. Frye, Ph.D.

Academics in CNS Therapy Discovery

The business of drug discovery is changing. Pharma has historically played the principal role in small molecule drug development, and academia has traditionally conducted the basic research studies, providing pharma with the molecular targets to...

Brain Science Institute NeuroTranslational Drug Discovery Program

Johns Hopkins University

Presenter: Barbara Slusher, Ph.D., M.A.S.

Alternative Approaches To Lead Generation

Historically, drug discovery was chiefly an empirical enterprise, with the shift to a more hypothesis-driven approach occurring in the 20th century. Whereas originally drug discovery was focused primarily on identifying therapeutically useful agents...

University of Kansas Medical Center

Presenter: S.J. Enna, Ph.D.

Big data in drug safety

Safety and efficacy information on drugs shall be communicated to all stakeholders, including physicians, patients, insurers and investors, in a format that allows objective assessment of real value of the intervention compared to other treatments....


Presenter: Veronika Valdova

Biopharmaceutical Development and QA/QC

This collection of biopharmaceutical applications will help you find the right solution for your analytical needs.

Agilent Technologies

Presenter: Agilent Technologies

Can we Treat MS?

Current therapies for MS, an autoimmune neuroinflammatory disease, target the immune part of the disease but current drug discovery efforts focus on treating and even reversing progressive disease. Check out the recent discussion on new research and...

Charles River

Presenter: Antti Nurmi, PhD, Director of Science

Changing Landscape of Drug Discovery in Industry Settings

This lecture entitled “Changing Landscape of Drug Discovery in Industry Settings” introduces the drug discovery and development process to a class focused on a range of topics related to discovery and development of new therapeutic agents...

Vanderbilt Center for Neuroscience Drug Discovery

Vanderbilt University

Presenter: P. Jeffrey Conn

Compliance for Biopharmaceutical Laboratories

This primer is intended to introduce FDA and equivalent international requirements. The primer will also give strategies and specific recommendations for regulated laboratories on how to implement the requirements in the most cost effective way.

Agilent Technologies

Presenter: Agilent Technologies

Drug Discovery and the Biopharmaceutical Ecosystem: The Imperative for New R&D Models “The Evolving Role of Academic Drug Discovery”

This presentation by Dr. Steven Paul was the keynote address for the "Johns Hopkins Brain Science Institute's Drug Discovery in Academia: The new paradigm in drug discovery" conference.'

Weill Cornell Medical College of Cornell University

Presenter: Steven M. Paul, M.D.